These chemicals do not directly stimulate KIF17, but rather modify the cellular environment in a way that influences KIF17's activity. Microtubule stabilizers and disruptors are two key classes within this group. Taxol (Paclitaxel), a well-known microtubule stabilizer, can indirectly affect KIF17's motor function by maintaining the integrity of microtubules, on which KIF17 travels. Conversely, Nocodazole and Vinblastine, both microtubule disruptors, impact KIF17 function by destabilizing microtubules, altering the tracks on which KIF17 operates. Similarly, Colchicine, which inhibits microtubule polymerization, can indirectly affect KIF17 function by altering the microtubule network.
Another member of this class is Kinesore, a small molecule inhibitor of kinesin motors. By inhibiting kinesin motors, Kinesore can have an impact on KIF17's activity, as KIF17 belongs to the kinesin-like protein family. It's important to note that the way these chemicals influence KIF17 is through their effects on the microtubules or the Kinesin motors, not by directly acting on KIF17 itself. Kinesore, a small molecule inhibitor of kinesin motors, represents another approach to influencing KIF17. KIF17 belongs to the kinesin-like protein family, and by inhibiting kinesin motors, Kinesore can impact the activity of KIF17. Although it does not directly act on KIF17, it affects the broader family of proteins to which KIF17 belongs, thus creating an indirect effect. In conclusion, the term KIF17 Activators encompasses a variety of chemicals that indirectly influence KIF17 activity by modulating the cellular environment, specifically the microtubule dynamics and the function of kinesin motors. The precise mechanisms and extent of influence these chemicals have on KIF17 function can vary depending on their concentration, cellular context, and interaction with other cellular components.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol is a microtubule stabilizer. By stabilizing microtubules, it can indirectly affect KIF17's motor function. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole is a microtubule disruptor. Changes in microtubule dynamics can have an impact on KIF17 activity. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine is a microtubule-destabilizing drug that can affect KIF17 function. | ||||||
Colchicine | 64-86-8 | sc-203005 sc-203005A sc-203005B sc-203005C sc-203005D sc-203005E | 1 g 5 g 50 g 100 g 500 g 1 kg | $100.00 $321.00 $2289.00 $4484.00 $18207.00 $34749.00 | 3 | |
Colchicine is an agent in research that can inhibit microtubule polymerization, potentially affecting the function of KIF17. | ||||||